Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD

被引:20
作者
Linge, Jennifer [1 ,2 ,7 ]
Nasr, Patrik [3 ,4 ]
Sanyal, Arun J. [5 ]
Leinhard, Olof Dahlqvist [1 ,2 ,6 ]
Ekstedt, Mattias [3 ,4 ,6 ]
机构
[1] AMRA Med AB, Linkoping, Sweden
[2] Linkoping Univ, Dept Hlth Med & Caring Sci, Div Diagnost & Specialist Med, Linkoping, Sweden
[3] Linkoping Univ, Dept Gastroenterol & Hepatol, Linkoping, Sweden
[4] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden
[5] VCU Sch Med, Stravitz Sanyal Inst Liver Dis & Metab Hlth, Dept Internal Med, Richmond, VA USA
[6] Linkoping Univ, Ctr Med Image Sci & Visualizat CMIV, Linkoping, Sweden
[7] Badhusgatan 5, S-58222 Linkoping, Sweden
关键词
sarcopenia; Magnetic resonance imaging; Imaging biomarker; survival; Muscle fat infiltration; Myosteatosis; UK Biobank; FATTY LIVER-DISEASE; FIBROSIS STAGE; SARCOPENIA; MANAGEMENT; HEALTH; TIME;
D O I
10.1016/j.jhepr.2022.100663
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Adverse muscle composition (MC) (i.e., low muscle volume and high muscle fat) has previously been linked to poor functional performance and comorbidities in non-alcoholic fatty liver disease (NAFLD). In this study we aimed to investigate associations of all-cause mortality with liver fat, NAFLD, and MC in the UK Biobank imaging study.Methods: Magnetic resonance images of 40,174 participants were analyzed for liver proton density fat fraction (PDFF), thigh fat-free muscle volume (FFMV) z-score, and muscle fat infiltration (MFI) using the AMRA (R) Researcher. Participants with NAFLD were sex-, age-, and BMI-matched to participants without NAFLD with low alcohol consumption. Adverse MC was identified using previously published cut-offs. All-cause mortality was investigated using Cox regression. Models within NAFLD were crude and subsequently adjusted for sex, age, BMI (M1), hand grip strength, physical activity, smoking, alcohol (M2), and previous cancer, coronary heart disease, type 2 diabetes (M3).Results: A total of 5,069 participants had NAFLD. During a mean (+/- SD) follow-up of 3.9 (+/- 1.4) years, 150 out of the 10,138 participants (53% men, age 64.4 [+/- 7.6] years, BMI 29.7 [+/- 4.4] kg/m2) died. In the matched dataset, neither NAFLD nor liver PDFF were associated with all-cause mortality, while all MC variables achieved significance. Within NAFLD, adverse MC, MFI and FFMV z-score were significantly associated with all-cause mortality and remained so in M1 and M2 (crude hazard ratios [HRs] 2.84, 95% CI 1.70-4.75, p <0.001; 1.15, 95% CI 1.07-1.24, p <0.001; 0.70, 95% CI 0.55-0.88, p <0.001). In M3, the rela-tionship was attenuated for adverse MC and FFMV z-score (adjusted HRs 1.72, 95% CI 1.00-2.98, p = 0.051; 0.77, 95% CI 0.58-1.02, p = 0.069) but remained significant for MFI (adjusted HR 1.13, 95% CI 1.01-1.26, p = 0.026).Conclusions: Neither NAFLD nor liver PDFF was predictive of all-cause mortality. Adverse MC was a strong predictor of all -cause mortality in individuals with NAFLD.Impact and implications: Individuals with fatty liver disease and poor muscle health more often suffer from poor functional performance and comorbidities. This study shows that they are also at a higher risk of dying. The study results indicate that measuring muscle health (the patient's muscle volume and how much fat they have in their muscles) could help in the early detection of high-risk patients and enable targeted preventative care.(c) 2022 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:11
相关论文
共 50 条
[1]   Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease [J].
Angulo, Paul ;
Kleiner, David E. ;
Dam-Larsen, Sanne ;
Adams, Leon A. ;
Bjornsson, Einar S. ;
Charatcharoenwitthaya, Phunchai ;
Mills, Peter R. ;
Keach, Jill C. ;
Lafferty, Heather D. ;
Stahler, Alisha ;
Haflidadottir, Svanhildur ;
Bendtsen, Flemming .
GASTROENTEROLOGY, 2015, 149 (02) :389-+
[2]   Reproducibility and repeatability of MRI-based body composition analysis [J].
Borga, Magnus ;
Ahlgren, Andre ;
Romu, Thobias ;
Widholm, Per ;
Leinhard, Olof Dahlqvist ;
West, Janne .
MAGNETIC RESONANCE IN MEDICINE, 2020, 84 (06) :3146-3156
[3]   A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation [J].
Carey, Elizabeth J. ;
Lai, Jennifer C. ;
Sonnenday, Christopher ;
Tapper, Elliot B. ;
Tandon, Puneeta ;
Duarte-Rojo, Andres ;
Dunn, Michael A. ;
Tsien, Cynthia ;
Kallwitz, Eric R. ;
Ng, Vicky ;
Dasarathy, Srinivasan ;
Kappus, Matthew ;
Bashir, MustafaR. ;
Montano-Loza, Aldo J. .
HEPATOLOGY, 2019, 70 (05) :1816-1829
[4]   Clinical Definitions of Sarcopenia and Risk of Hospitalization in Community-Dwelling Older Men: The Osteoporotic Fractures in Men Study [J].
Cawthon, Peggy M. ;
Lui, Li-Yung ;
Taylor, Brent C. ;
McCulloch, Charles E. ;
Cauley, Jane A. ;
Lapidus, Jodi ;
Orwoll, Eric ;
Ensrud, Kristine E. .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2017, 72 (10) :1383-1389
[5]   Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis [J].
Chakravarthy, Manu V. ;
Siddiqui, Mohammad S. ;
Forsgren, Mikael F. ;
Sanyal, Arun J. .
FRONTIERS IN ENDOCRINOLOGY, 2020, 11
[6]   Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment [J].
Chen, Liang-Kung ;
Woo, Jean ;
Assantachai, Prasert ;
Auyeung, Tung-Wai ;
Chou, Ming-Yueh ;
Iijima, Katsuya ;
Jang, Hak Chul ;
Kang, Lin ;
Kim, Miji ;
Kim, Sunyoung ;
Kojima, Taro ;
Kuzuya, Masafumi ;
Lee, Jenny S. W. ;
Lee, Sang Yoon ;
Lee, Wei-Ju ;
Lee, Yunhwan ;
Liang, Chih-Kuang ;
Lim, Jae-Young ;
Lim, Wee Shiong ;
Peng, Li-Ning ;
Sugimoto, Ken ;
Tanaka, Tomoki ;
Won, Chang Won ;
Yamada, Minoru ;
Zhang, Teimei ;
Akishita, Masahiro ;
Arai, Hidenori .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (03) :300-+
[7]   Sarcopenia: revised European consensus on definition and diagnosis (vol 48, pg 16, 2019) [J].
Cruz-Jentoft, Alfonso J. ;
Bahat, Gulistan ;
Bauer, Jurgen ;
Boirie, Yves ;
Bruyere, Olivier ;
Cederholm, Tommy ;
Cooper, Cyrus ;
Landi, Francesco ;
Rolland, Yves ;
Sayer, Avan Aihie ;
Schneider, Stephane M. ;
Sieber, Cornel C. ;
Topinkova, Eva ;
Vandewoude, Maurits ;
Visser, Marjolein ;
Zamboni, Mauro .
AGE AND AGEING, 2019, 48 (04)
[8]   Cause and management of muscle wasting in chronic liver disease [J].
Dasarathy, Srinivasan .
CURRENT OPINION IN GASTROENTEROLOGY, 2016, 32 (03) :159-165
[9]   Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity? [J].
De Fre, C. H. ;
De Fre, M. A. ;
Kwanten, W. J. ;
Op de Beeck, B. J. ;
Van Gaal, L. F. ;
Francque, S. M. .
OBESITY REVIEWS, 2019, 20 (02) :353-363
[10]   Increased Risk of Mortality by Fibrosis Stage in Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis [J].
Dulai, Parambir S. ;
Singh, Siddharth ;
Patel, Janki ;
Soni, Meera ;
Prokop, Larry J. ;
Younossi, Zobair ;
Sebastiani, Giada ;
Ekstedt, Mattias ;
Hagstrom, Hannes ;
Nasr, Patrik ;
Stal, Per ;
Wong, Vincent Wai-Sun ;
Kechagias, Stergios ;
Hultcrantz, Rolf ;
Loomba, Rohit .
HEPATOLOGY, 2017, 65 (05) :1557-1565